In many cancers, non-small cell lung cancer (NSCLC) in particular, NRF2 is constitutively active promoting growth and rendering cells resistant to chemo- and radiotherapy [[6], [7], [8]]. The gene discussed is NFE2L2; the disease is non-small cell lung carcinoma.